Turning foes to friends: Advanced “in situnanovaccine” with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer

MLA

Wang, Ze, et al. “Turning Foes to Friends: Advanced ‘in Situnanovaccine’ with Dual Immunoregulation for Enhanced Immunotherapy of Metastatic Triple-Negative Breast Cancer.” Bioactive Materials, vol. 39, no. 1, Sept. 2024, pp. 612–29. EBSCOhost, https://doi.org/10.1016/j.bioactmat.2024.04.023.

APA

Wang, Z., Sha, T., Li, J., Luo, H., Liu, A., Liang, H., Qiang, J., Li, L., Whittaker, A. K., Yang, B., Sun, H., Shi, C., & Lin, Q. (2024). Turning foes to friends: Advanced “in situnanovaccine” with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer. Bioactive Materials, 39(1), 612–629. https://doi.org/10.1016/j.bioactmat.2024.04.023

Chicago

Wang, Ze, Tong Sha, Jinwei Li, Huanyu Luo, Annan Liu, Hao Liang, Jinbiao Qiang, et al. 2024. “Turning Foes to Friends: Advanced ‘in Situnanovaccine’ with Dual Immunoregulation for Enhanced Immunotherapy of Metastatic Triple-Negative Breast Cancer.” Bioactive Materials 39 (1): 612–29. doi:10.1016/j.bioactmat.2024.04.023.